PERTH, Australia, Jan. 7, 2025 /PRNewswire/ — Argent BioPharma (ASX:RGT) (OTCQB:RGTLF), a clinical-stage biopharmaceutical company addressing…
PERTH, Australia, Jan. 7, 2025 /PRNewswire/ — Argent BioPharma (ASX:RGT) (OTCQB:RGTLF), a clinical-stage biopharmaceutical company addressing…